Headlines about Phibro Animal Health Corp (NASDAQ:PAHC) have been trending somewhat positive this week, AlphaOne reports. The research firm, a unit of Accern, identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real time. AlphaOne ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Phibro Animal Health Corp earned a daily sentiment score of 0.14 on AlphaOne’s scale. AlphaOne also gave news stories about the company an impact score of 57 out of 100, meaning that recent news coverage is somewhat likely to have an effect on the company’s share price in the immediate future.
Here are some of the news stories that may have impacted AlphaOne’s analysis:
- Insider Selling: Phibro Animal Health Corp (PAHC) Insider Sells 48,000 Shares of Stock (americanbankingnews.com)
- ETFs with exposure to Phibro Animal Health Corp. : May 16, 2017 (finance.yahoo.com)
- Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q3, 2017 By the Numbers : May 15, 2017 (finance.yahoo.com)
- Edited Transcript of PAHC earnings conference call or presentation 9-May-17 1:00pm GMT (finance.yahoo.com)
Phibro Animal Health Corp (NASDAQ:PAHC) traded down 0.73% on Friday, reaching $34.10. 98,851 shares of the company’s stock traded hands. The stock has a 50 day moving average price of $29.68 and a 200 day moving average price of $28.49. Phibro Animal Health Corp has a 12-month low of $17.96 and a 12-month high of $35.15. The stock has a market cap of $1.35 billion, a price-to-earnings ratio of 21.18 and a beta of 1.34.
Phibro Animal Health Corp (NASDAQ:PAHC) last released its quarterly earnings data on Monday, May 8th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. The business had revenue of $190 million for the quarter, compared to the consensus estimate of $185.90 million. Phibro Animal Health Corp had a net margin of 7.90% and a return on equity of 63.70%. The business’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.38 EPS. Analysts forecast that Phibro Animal Health Corp will post $1.45 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 22nd. Stockholders of record on Wednesday, May 31st will be issued a $0.10 dividend. This represents a $0.40 annualized dividend and a dividend yield of 1.16%. The ex-dividend date of this dividend is Friday, May 26th. Phibro Animal Health Corp’s dividend payout ratio (DPR) is currently 26.85%.
PAHC has been the topic of several research reports. Piper Jaffray Companies raised their target price on shares of Phibro Animal Health Corp from $32.00 to $34.00 and gave the stock an “overweight” rating in a report on Wednesday, February 8th. Zacks Investment Research upgraded shares of Phibro Animal Health Corp from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a report on Thursday, May 11th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $29.17.
COPYRIGHT VIOLATION WARNING: This story was originally reported by Mideast Time and is owned by of Mideast Time. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://www.mideasttime.com/phibro-animal-health-corp-pahc-earning-somewhat-favorable-media-coverage-analysis-shows/1708616.html.
In other news, Director Gerald K. Carlson sold 12,000 shares of the company’s stock in a transaction on Monday, February 27th. The shares were sold at an average price of $28.29, for a total value of $339,480.00. Following the sale, the director now directly owns 12,000 shares of the company’s stock, valued at approximately $339,480. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gerald K. Carlson sold 63,338 shares of the company’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $33.31, for a total transaction of $2,109,788.78. Following the completion of the sale, the director now directly owns 50 shares in the company, valued at $1,665.50. The disclosure for this sale can be found here. Insiders sold a total of 235,296 shares of company stock worth $7,505,834 over the last ninety days. Insiders own 48.09% of the company’s stock.
Phibro Animal Health Corp Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.